The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo

American Journal of Transplantation

Volumn 5, Issue 11, 2005, Pages 2649-2659

  Lan, Yuk Yuen ^a,b   De Creus, An ^a   Colvin, Bridget L ^a   Abe, Masanori ^a   Brinkmann, Volker ^c   Coates, P Toby H ^a   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adhesion molecules; Cell trafficking; Dendritic cells; FTY720

Indexed keywords

5 (4 PHENYL 5 TRIFLUOROMETHYLTHIOPHEN 2 YL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; CD11B ANTIGEN; CD31 ANTIGEN; CHEMOKINE RECEPTOR CCR7; FINGOLIMOD; FLUOROCHROME; G PROTEIN COUPLED RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; OXADIAZOLE DERIVATIVE; SEW 2871; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PRIMER DNA; PROPANEDIOL DERIVATIVE; SEW2871; SPHINGOSINE; THIOPHENE DERIVATIVE;

ADOLESCENT; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL TRANSPORT; CONTROLLED STUDY; DENDRITIC CELL; GRAFT REJECTION; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INFLAMMATION; LYMPH NODE; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ANIMAL; APOPTOSIS; B LYMPHOCYTE; C3H MOUSE; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE DEPLETION; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; DENDRITIC CELLS; DNA PRIMERS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; OXADIAZOLES; POLYMERASE CHAIN REACTION; PROPYLENE GLYCOLS; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE; T-LYMPHOCYTES; THIOPHENES;

EID: 33644791607     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01085.x     Document Type: Article

References (48)

1. Brinkmann V Davis MD Heise CE et al. The immune modulator, FTY720, targets sphingosine-1-phosphate receptors. J Biochem 2002 277: 21453 21457.
2. Kiuchi M Adachi K Kohara T et al. Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols. J Med Chem 2000 43: 2946 2961.
3. Kahan BD. FTY720: from bench to bedside. Transplant Proc 2004 36 ( Suppl 2S 531S 543S.
4. Pinschewer DD Ochsenbein AF Odermatt B Brinkmann V Hengartner H Zinkernagel RM. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol 2000 164: 5761 5770.
5. Budde K Schmouder R Brunkhorst R et al. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients. J Am Soc Nephrol 2002 13: 1073 1083.
6. Chiba K Yanagawa Y Masubuchi Y et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998 160: 5037 5044.
7. Yanagawa Y Sugahare K Kataoka H Kawaguchi T Masubuchi Y Chiba K. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin sllograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 1998 160: 5493 5499.
8. Mandala S Hajdu R Bergstrom J et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002 296: 346 349.
9. Chiba K Hoshino Y Suzuki S et al. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplant Proc 1996 28: 1056 1059.
10. Hoshino Y Suzuki S Ohtsuki M Masubuchi Y Amano Y Chiba K. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Transplant Proc 1996 28: 1060 1061.
11. Kawaguchi T Hoshino Y Rahman F et al. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A. Transplant Proc 1996 28: 1062 1063.
12. Schuurman H-J Menninger K Audet M et al. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney transplantation, given alone or in combination with cyclosporine or RAD. Transplantation 2002 74: 951 960.
13. Kahan BD Karlix JL Ferguson RM et al. Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study. Transplantation 2003 76: 1079 1084.
14. Tedesco-Silva H Mourad G Kahan BD et al. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation 2005 79: 1553 1560.
15. Rosen H Sanna G Alfonso C. Egress: a receptor-regulated step in lymphocyte trafficking. Immunol Rev 2003 195: 160 177.
16. Srinivasan S Wang F Glavas S et al. Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis. J Cell Biol 2003 160: 375 385.
17. Burns S Thrasher AJ Blundell MP Machesky L Jones GE. Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood 2001 98: 1142 1149.
18. Rosen H Goetzl EJ. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 2005 5: 560 570.
19. Brinkmann V Cyster JG Hla T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 2004 4: 1019 1025.
20. Banchereau J Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392: 245 252.
21. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991 9: 271 296.
22. Coates PT Thomson AW. Dendritic cells, tolerance induction and transplant outcome. Am J Transplant 2002 2: 299 307.
23. Steinman RM Hawiger D Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003 21: 685 711.
24. Morelli AE Thomson AW. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003 196: 125 146.
25. Idzko M Panther E Corinti S et al. Sphingosine 1-phosphate induces chemotaxis of immature dendritic cells and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune response. FASEB J 2002 6: 625 627.
26. Muller H Hofer S Kaneider N et al. The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur J Immunol 2005 35: 533 545.
27. Colvin BL Morelli AE Logar AJ Lau AH Thomson AW. Comparative evaluation of CC chemokine-induced migration of murine CD8alpha+ and CD8alpha- dendritic cells and their in vivo trafficking. J Leukoc Biol 2004 75: 275 285.
28. Morelli AE Zahorchak AF Larregina AT et al. Cytokine production by mouse dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood 2001 98: 1512 1523.
29. Hackstein H Taner T Zahorchak AF et al. Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 2003 101: 4457 4463.
30. O'Connell PJ Li W Wang Z Specht SM Logar AJ Thomson AW. Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts. J Immunol 2002 168: 143 154.
31. Colvin BL Morelli AE Logar AJ Lau AH Thomson AW. Comparative evaluation of CC chemokine-induced migration of murine CD8alpha+ and CD8alpha- dendritic cells and their in vivo trafficking. J Leukocyte Biol 2004 75: 275 285.
32. Morelli AE Antonysamy MA Takayama T et al. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus. J Immunol 2000 165: 226 237.
33. Hla T Lee MJ Ancellin N Paik JH Kluk MJ. Lysophospholipids-receptor revelations. Science 2001 294: 1875 1878.
34. Larsen CP Morris PJ Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med 1990 171: 307 314.
35. Dieu MC Vanbervliet B Vicari A et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998 188: 373 386.
36. Sallusto F Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000 177: 134 140.
37. Sanna MG Liao J Jo E et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem 2004 279: 13839 13848.
38. Yopp AC Randolph GJ Bromberg JS. Leukotrienes, sphingolipids, and leukocyte trafficking. J Immunol 2003 171: 5 10.
39. Randolph GJ. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin Immunol 2001 13: 267 274.
40. Randolph GJ Sanchez-Schmitz G Angeli V. Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances. Springer Semin Immunopathol 2005 26: 273 287.
41. Bianchi G D'Amico G Varone L Sozzani S Mantovani A Allavena P. In vitro studies on the trafficking of dendritic cells through endothelial cells and extra-cellular matrix. Dev Immunol 2000 7: 143 153.
42. de la Rosa G Longo N Rodriguez-Fernandez JL et al. Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration. J Leukocyte Biol 2003 73: 639 649.
43. Shang XZ Issekutz AC. Contribution of CD11a/CD18, CD11b/CD18, ICAM-1 (CD54) and -2 (CD102) to human monocyte migration through endothelium and connective tissue fibroblast barriers. Eur J Immunol 1998 28: 1970 1979.
44. Vuckovic S Kim M Khalil D et al. Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression. Blood 2003 101: 2314 2317.
45. Kamath AT Pooley J O'Keeffe MA et al. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol 2000 165: 6762 6770.
46. Matloubian M Lo CG Cinamon G et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004 427: 355 360.
47. Budde K, R LS, Nashan B et al. Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients. Am J Transplant 2003 3: 846 854.
48. Brinkmann V Lynch KR. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr Opin Immunol 2002 14: 569 575.